RETRACTED ARTICLE: Clinical adverse events to letairis: a real-world drug safety study based on FDA Adverse Event Reporting System (FAERS)

We, the Editor and Publisher of Expert Opinion on Drug Safety, are retracting the following article: Bi, Y. T. & Dong, B. (2024). Clinical adverse events to letairis: a real-world drug safety study based on FDA Adverse Event Reporting System (FAERS). Expert Opinion on Drug Safety, 1–8. https://doi.org/10.1080/14740338.2024.2416243 Following publication, it has come to our attention that Dr. Dong was listed as a co-author on this publication without his consent, using an email address not associated with him. As this is a breach of our editorial policies, we have retracted the article. The authors have been informed with this decision. The corresponding author, Dr. Dong, agrees with the retraction and the other author has been informed. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.